TickerKhojComparison · NSE · data 2026-11-03
Senores Pharmaceuticals Ltd. vs Sun Pharma Advanced Research Co. Ltd.
In plain words
Size: Sun Pharma Advanced Research Co. Ltd. is about 1.1 times the market value of Senores Pharmaceuticals Ltd..
Valuation (P/E): Senores Pharmaceuticals Ltd. 39.7 vs Sun Pharma Advanced Research Co. Ltd. 3.5.
Return on equity: Sun Pharma Advanced Research Co. Ltd. 276.9% vs Senores Pharmaceuticals Ltd. 13.4%.
Debt to equity: Sun Pharma Advanced Research Co. Ltd. 0.42 vs Senores Pharmaceuticals Ltd. 0.37.
Differences in the numbers, not a recommendation of either stock.
Side by side
19 metrics shown
| SENORES | SPARC | |
|---|---|---|
| Price | ₹1,147 | ₹175.74 |
| Market cap | ₹5,157 cr | ₹5,682 cr |
| P/E | 39.7 | 3.5 |
| P/B | 5.3 | 4 |
| ROE | 13.4% | 276.9% |
| ROCE | 12.6% | 232.1% |
| Debt / equity | 0.37 | 0.42 |
| Operating margin | 24.3% | 84.3% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 161.6% | 98.9% |
| Profit growth, 3 years (yearly) | 139.2% | — |
| 1-year return | 48.7% | 30.0% |
| Revenue, last 12 months | ₹722 cr | ₹1,932 cr |
| Net profit, last 12 months | ₹133 cr | ₹1,636 cr |
| Latest quarter | Sept 2026 | Sept 2026 |
| Quarter net profit | ₹39 cr | ₹-24 cr |
| Quarter profit vs a year earlier | +22.0% | — |
| Promoter holding | 45.82% | 65.67% |
| Health check | Strong (7.2/10) | Strong (8.7/10) |
Common questions
Which has a higher P/E, Senores Pharmaceuticals Ltd. or Sun Pharma Advanced Research Co. Ltd.?
Senores Pharmaceuticals Ltd. trades at the higher P/E (39.7 against 3.5). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Sun Pharma Advanced Research Co. Ltd. (276.9% against 13.4%).
Which carries more debt?
Sun Pharma Advanced Research Co. Ltd. has the higher debt-to-equity ratio (0.42 against 0.37).